Gut microbiome-related interventions for the management of disorders of gut-brain interaction were on the agenda of NeuroGASTRO 2025. In this video interview, Dr. Juan M. Mendive delves into the role of the gut microbiome for improving outcomes of primary care patients with IBS.
Disorders of gut-brain interaction (DGBI), previously known as functional gastrointestinal disorders (eg, functional dyspepsia and irritable bowel syndrome), are commonly encountered in primary care and their management can often be challenging1.
The gut microbiome could offer a new perspective for the primary care clinician to better help patients with DGBI2, particularly given patients’ high interest in dietary interventions targeting the gut microbiome to improve gut and overall health.
In this new interview, Juan M. Mendive, MD, PhD, a family physician in Barcelona (Spain) and president of the European Society for Primary Care Gastroenterology, shares his views on the current and future role of targeting the gut microbiome in primary care patients with IBS.
This insightful interview will explore the optimal approach to managing patients with IBS, the role of effective communication, the benefits of probiotics, and the future of microbiome-based care in primary care practice.
Whether you are a healthcare professional, researcher, or advocate for patient-centered care, this interview is worth watching.
References:
- Koloski NA, Jones MP, Shah A, et al. Evidence for brain-to-gut and gut-to-brain pathways in primary care patients with disorders of gut-brain interaction, inflammatory bowel disease and gastroesophageal reflux disease. Neurogastroenterol Motil. 2025; 37(12):e70117. doi: 10.1111/nmo.70117.
- Miller EM. Update on the gut microbiome for the primary care clinician. J Fam Pract. 2022; 71(6 Suppl):S76-S81. doi: 10.12788/jfp.0406.
